Status report
Get it in writing
The official USPTO status record for VACCRIX REIMBURSEMENT HOTLINE, serial 78112933, as a dated PDF. One price, one document, delivered in about a minute.
INSTANT DELIVERY
Trademark Status Report
$7.99
The USPTO's own status record for this mark, on one dated page.
- Current status with a plain-English verdict
- Owner, classes, filing basis, and every key date
- The mark as it appears on the federal record
- Every prosecution event, filing to today
- Source-cited with the exact retrieval date
Built from the USPTO's TSDR record. Assignment chain of title and TTAB proceeding files sit in separate USPTO systems and are not included.
Preview
◆ TRADEMARKCHECKER.AITRADEMARK STATUS REPORT
VACCRIX REIMBURSEMENT HOTLINESerial 78112933 · Principal Register
Dead · Cancelled
Owner: GLAXOSMITHKLINE LLC
Class 035 - Advertising & Business
Filed Mar 06, 2002
Registered May 03, 2005
The record shows that “VACCRIX REIMBURSEMENT HOTLINE” is a cancelled Principal Register service mark, with the cancellation dated December 9 2011 because the registrant did not file an acceptable Section 8 declaration; the owner listed is GlaxoSmithKline LLC, a Delaware limited‑liability company. The registration covered Class 035 services described as “vaccine reimbursement services, namely, administering vaccine‑related pharmacy reimbursement programs and services,” so a similar name used for any vaccine‑related reimbursement or pharmacy assistance would be the closest record‑based concern. The record does not give GlaxoSmithKline control over every use of the words “vaccrix,” “reimbursement,” or “hotline” in other industries or contexts. Because the mark was on the Principal Register, there is no Supplemental Register sequence to note. The latest meaningful event is the Section 8 cancellation, and the supplied history shows no oppositions, cancellations by others, or court actions. I'd treat this as a moderate concern if you plan a name that touches vaccine reimbursement services.
Full event history, owner details, and verdict inside.
The way I'd use it, honestly, is as the thing you attach when a bank, a marketplace, or a co-founder asks "are we clear on the name". It answers in one page.